AC
CLB icon

Allstate Corporation’s Core Laboratories CLB Stock Holding History

Allstate Corporation’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,812
Closed -$153K – 679
2020
Q1 		$153K Sell
14,812
-9,715
-40% -$272K 0.01% 602
2019
Q4 		$924K Buy
+24,527
New +$1.1M 0.02% 438

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Allstate Corporation's CLB Position: Q2 2020 in Review

Allstate Corporation sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 14,812 shares — an estimated $153K sold.

Allstate Corporation first reported a position in CLB in Q4 2019 and held it in 2 quarters. The position peaked at $924K in Q4 2019. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • Allstate Corporation reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
  • Allstate Corporation sold 14,812 Core Laboratories shares in Q2 2020, an estimated $153K.
  • Allstate Corporation first reported a position in Core Laboratories in Q4 2019 and held it in 2 quarters.
  • Allstate Corporation's Core Laboratories position peaked at $924K in Q4 2019.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on Allstate Corporation's 13F filing for Q2 2020, filed 13 Aug 2020.